XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
  X Chromosome
  Genetic Disorders
  Cloning
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
 
 India
Search

Last Updated: Nov 18, 2006 - 12:32:53 PM

Genetics Channel
subscribe to Genetics newsletter

Latest Research : Genetics

   DISCUSS   |   EMAIL   |   PRINT
Gene therapy helps two Germans in global first
Apr 3, 2006 - 2:38:00 PM, Reviewed by: Dr. Priya Saxena

Dorothee von Laer, gene therapy coordinator at the Georg Speyer laboratory in Frankfurt, said two adult males aged 25 and 26 had been treated for a hereditary autoimmune disease over the past two years at Frankfurt University Hospital.

 
For the first time, gene therapy has been used to alter the cells of sick adults and allow them greater resistance to bacteria and fungi, a Germany-based team of scientists said.

The research was described in the online version of the journal Nature Medicine. The cutting-edge techniques have mainly been used in the past to help sick children.

Dorothee von Laer, gene therapy coordinator at the Georg Speyer laboratory in Frankfurt, said two adult males aged 25 and 26 had been treated for a hereditary autoimmune disease over the past two years at Frankfurt University Hospital.

She said the new technique might prove suitable for other diseases where people are born with a defective gene.

The team of 27 scientists was able to raise above 50 percent the proportion of healthy immune cells in the men's blood, leading to a lessening of infection and avoiding serious new infections.

The rare condition the two men suffer from is termed chronic granulomatous disease - their bodies cannot kill invading bacteria and fungi and they often have internal infections. Currently the disease is treated using bone-marrow transplants.

The scientists took blood stem cells from the men and introduced a healthy gene to the cells. The cells were then re-injected into the men. The key to the technique was a new, more efficient method of inserting the genes in many cells at the same time.

Concern remains that such therapy could have a negative side effect: causing cancer of the blood. Research is continuing on how to make such techniques safer.
 

- The research was described in the online version of the journal Nature Medicine.
 

 
Subscribe to Genetics Newsletter
E-mail Address:

 

Indo-Asian News Service

Related Genetics News

New research into csd genes could help designing strategies for breeding honey bees
Williams Syndrome, the brain and music
Genetic mutation identified as cause of cranio-lenticulo-sutural dysplasia
Chance Fluctuations in mRNA Output in Mammalian Cells
Transposon Silencing Keeps Jumping Genes in Their Place
GATA2 - predicting susceptibility to coronary artery disease
Exploring genetics of congenital malformations
Genome insertions and deletions (INDELs) provide expanded view of human genetic differences
BRIT1 gene identified as protector of DNA
FDA Approves Idursulfase As First Treatment for Hunter Syndrome


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us